NDADENTALPOWDER, EXTENDED RELEASE
Approved
Feb 2001
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
5/8 — Partial
ARESTIN (minocycline hydrochloride) by Fosun Pharma is mechanism of action the mechanism of action of arestin as an adjunct to scaling and root planing procedures for reduction of pocket depth in patients with adult periodontitis is unknown. First approved in 2001.
Drug data last refreshed 18h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ARESTIN is a minocycline hydrochloride powder formulation administered as a dental adjunct to scaling and root planing for adult periodontitis. The exact mechanism of action remains unknown, though minocycline is believed to have anti-inflammatory and antimicrobial properties. It represents a niche dental therapeutic with limited systemic absorption.
$6.0MPart D
LOE ApproachingMinimal commercial activity with only 1,283 Part D claims in 2023; likely a small, declining team focused on specialty dental channels.
Mechanism of Action
Mechanism of Action The mechanism of action of ARESTIN as an adjunct to scaling and root planing procedures for reduction of pocket depth in patients with adult periodontitis is unknown.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel
Started Nov 2014
47 enrolled
Acute PainBreast CarcinomaPeripheral Neuropathy
Career Relevance
ARESTIN offers minimal career opportunity; zero linked job openings and declining commercial activity suggest limited hiring and career progression. Professionals joining this product should expect a consolidation-focused role rather than growth-oriented challenges.
Dental Sales Representative
Worked on ARESTIN at Fosun Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.